OSL 0.00% 1.2¢ oncosil medical ltd

Ann: OncoSil AGM CEO Presentation, page-107

  1. Al.
    198 Posts.
    lightbulb Created with Sketch. 114
    Barton, M. B. et al. Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012. Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol. 112, 140–144 (2014). - ‘Radiation is used in approximately 50% of all cancer treatments1. The key objective in cancer radiotherapy is to achieve a high therapeutic efficacy by maximizing damage to the tumor whilst minimizing damage to surrounding healthy tissue2,3,4. In conventional external beam radiotherapy, the dose that can be delivered to a tumor is often limited by the presence of an adjacent critical organ. This means that not all tumor cells may receive a lethal dose of radiation, thus limiting the treatment efficacy.’
 
watchlist Created with Sketch. Add OSL (ASX) to my watchlist
(20min delay)
Last
1.2¢
Change
0.000(0.00%)
Mkt cap ! $45.40M
Open High Low Value Volume
1.2¢ 1.2¢ 1.1¢ $65.61K 5.632M

Buyers (Bids)

No. Vol. Price($)
14 6553895 1.1¢
 

Sellers (Offers)

Price($) Vol. No.
1.2¢ 1917493 5
View Market Depth
Last trade - 15.50pm 16/08/2024 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.